The FIRST and ONLY FDA-approved medication proven to reduce the size of PN*
*66% or 33 of 50 patients in the clinical study saw a 20% or more decrease in the size of their plexiform neurofibromas, confirmed by 3D magnetic resonance imaging (MRI) scan.
KOSELUGO® (selumetinib) is a prescription medicine that is used to treat children 2 years of age and older with neurofibromatosis type 1 (NF1) who have plexiform neurofibromas that cannot be completely removed by surgery. It is not known if Koselugo is safe and effective in children under 2 years of age.
Koselugo comes with a team
Connect with a Patient Education Manager (PEM) to get personal one-to-one support. PEMs are just one of the resources available through OneSource™.
Educational events
Explore live and virtual events that cover a range of topics that can help in the care of your child with NF1 PN. Registering is simple and free. Get started today.